Have a personal or library account? Click to login
Prosperity of community pharmacy evaluated by gross and net profit and suggested corrective measures. 10 years study / Prosperita verejnej lekárne hodnotená prostredníctvom hrubého a čistého zisku a opatrenia vedúce k ich náprave. 10 ročná štúdia Cover

Prosperity of community pharmacy evaluated by gross and net profit and suggested corrective measures. 10 years study / Prosperita verejnej lekárne hodnotená prostredníctvom hrubého a čistého zisku a opatrenia vedúce k ich náprave. 10 ročná štúdia

European Pharmaceutical Journal
Volume 62 (2015): Issue 1 (June 2015)
By: I. Malovecká,  K. Papargyris,  D. Mináriková,  V. Foltán and  A. Jankovská  
Open Access
|Jun 2015

References

  1. [1] Cheng Y, Raisch D W, Borrego ME, Gupchup GV. Research in Social and Administrative Pharmacy, 9(3), 2013, 311-329.10.1016/j.sapharm.2012.05.00422835704
    Search in Google Scholar
  2. [2] Ifanti AA, Argyriou AA, Kalofonou FH, Kalofonos HP. Financial crisis and austerity measures in Greece: Their impact on health promotion policies and public health care. Health Policy, 113 (1-2), 2013, 8-12.10.1016/j.healthpol.2013.05.01723790265
    Search in Google Scholar
  3. [3] Goranitis I, Siskou O, Liaropoulos L. Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece. Health Policy, Accepted Manuscript, Available online 1 August 201410.1016/j.healthpol.2014.07.01225150026
    Search in Google Scholar
  4. [4] Markovits Y, Boer D, van Dick R. Economic crisis and the employee: The effects of economic crisis on employee job satisfaction, commitment, and self-regulation. European Management Journal, 32 (3), 2014, 413-422.10.1016/j.emj.2013.09.005
    Search in Google Scholar
  5. [5] Jacobs S, Schafheutle EI, Jee SD, Elvey R, Hassell H, Noyce PR. Existing arrangements for monitoring community pharmacies in England: Can they have a role in the revalidation of pharmacists? Research in Social and Administrative Pharmacy, 9(2), 2013, 166-177.10.1016/j.sapharm.2012.07.00623517658
    Search in Google Scholar
  6. [6] Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: Implications for service provision, the public health function, and pharmacy’s claims to professional status in the United Kingdom. Research in Social and Administrative Pharmacy, 5(4), 2009, 305-318.10.1016/j.sapharm.2009.01.00319962674
    Search in Google Scholar
  7. [7] McMillan SS, Wheeler AJ, Sav A, King MA, Whitty JA, Kendall E, Kell F. Community pharmacy in Australia: A health hub destination of the future. Research in Social and Administrative Pharmacy, 9(6), 2013, 863-875.10.1016/j.sapharm.2012.11.00323218552
    Search in Google Scholar
  8. [8] Keast SL, Jacobs E, Harrison D, Farmer K, Thompson D. Future economic outlook of Nebraska rural community pharmacies based on break-even analysis of community operational costs and county population. Research in Social and Administrative Pharmacy, 6(3), 2010, 209-220.10.1016/j.sapharm.2009.07.00320813334
    Search in Google Scholar
  9. [9] Norris P, Horsburgh S, Sides G, Ram, Fraser J. Geographical access to community pharmacies in New Zealand. Health & Place, 29(1), 2014, 140-145.10.1016/j.healthplace.2014.07.00525087053
    Search in Google Scholar
  10. [10] Perepelkin J, Dobson RT. Influence of ownership type on role orientation, role affinity, and role conflict among community pharmacy managers and owners in Canada. Research in Social and Administrative Pharmacy, 6(4), 2010, 280-292.10.1016/j.sapharm.2009.11.00121111386
    Search in Google Scholar
  11. [11] Carroll NC, Miederhoff PA, Waters LW. Profitability, third-party reimbursement, and access to community pharmacies. Clinical Therapeutics, 8(4), 1996, 703-715.10.1016/S0149-2918(96)80221-9
    Search in Google Scholar
  12. [12] Herist N, Rollins B, Perri M. Financial Analysis in Pharmacy Practice. London: Pharmaceutical Press; 2011.
    Search in Google Scholar
  13. [13] Burke S, Thomas S, Barry S, Keegan C. Indicators of health system coverage and activity in Ireland during the economic crisis 2008-2014 - From ‘more with less’ to ‘less with less’. Health Policy, In Press, Corrected Proof, Available online 17 July 201410.1016/j.healthpol.2014.07.00125082466
    Search in Google Scholar
  14. [14] Vogler S, Habimana K, Art D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy, In Press, Corrected Proof, Available online 8 June 2014.10.1016/j.healthpol.2014.06.00124962537
    Search in Google Scholar
  15. [15] Matsaganis M, The Greek Crisis: Social Impact and Policy Responses, Department of Western Europe/North America, Berlin, 2013.
    Search in Google Scholar
  16. [16] de Belvis AG, Ferre F, Specchia MC, Valerio L, Fattore G, Ricciardi W. The financial crisis in Italy: Implications for the healthcare sector. Health Policy, 106(1), 2012, 10-16.10.1016/j.healthpol.2012.04.00322551787
    Search in Google Scholar
  17. [17] Ásgeirsdóttir TL, Corman H, Noonan K, Ólafsdóttir P, Reichman NE. Was the economic crisis of 2008 good for Icelanders? Impact on health behaviors. Economics & Human Biology, 13(1), 2014, 1-19.10.1016/j.ehb.2013.03.00523659821
    Search in Google Scholar
  18. [18] Sánchez-Serrano I. The World’s Health Care Crisis: The United States’ Leadership. The World’s Health Care Crisis, 2011, 3-28.10.1016/B978-0-12-391875-8.00001-9
    Search in Google Scholar
  19. [19] Söderberg IL, Wester M. Lay actions in the face of crisis-Swedish citizens’ actions in response to the global financial crisis of 2008. The Journal of Socio-Economics, 41(6), 2012, 796-805.10.1016/j.socec.2012.08.007
    Search in Google Scholar
  20. [20] Malovecká I, Mináriková D, Lehocká Ľ, Foltán V. New types of assessments of community pharmacy technology business and ther contribution towards prosperity of the community pharmacy. Acta Facultatis Pharmaceuticae Universitatis Comenianae. 2013, 60(1), 35-42.
    Search in Google Scholar
  21. [21] Smith M, Cannon-Breland ML, Spiggle S. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network. Research in Social and Administrative Pharmacy, 10 (3), 2014, 539-553.10.1016/j.sapharm.2013.08.00324055137
    Search in Google Scholar
  22. [22] Radford A, Mason M, Richardson I, Rutledge S, Poley S, Mueller K, Slifkin R. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community. Research in Social and Administrative Pharmacy, 5(1), 2009, 17-30.10.1016/j.sapharm.2008.04.00419285286
    Search in Google Scholar
DOI: https://doi.org/10.1515/afpuc-2015-0015 | Journal eISSN: 2453-6725
Journal RSS Feed
Language: English
Page range: 20 - 24
Submitted on: Jan 2, 2015
Accepted on: Apr 4, 2015
Published on: Jun 22, 2015
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Monitorovanie,
výpočet a hodnotenie prosperity verejnej lekárne pomocou metódy bolo uskutočnené za roky 2003 - 2012. Počítané boli ukazovatele ziskovosti,
ako hrubý zmeny,
ktoré nastali v rokoch 2003 až 2012. V dôsledku finančnej krízy,
recesie a vážnych hrubého zisku pohyboval v rozpätí x2003-2011 = 14,3 - 22,8 % (priemer = 19,2 %,
median 14,3 %. Ukazovateľ čistého zisku sa pohyboval v rozpätí x2003-2011 = 0 - 18,3 % (priemer čo v roku 2012 dosiahol len 2,3 %. Zmeny ktoré prebehli v spoločnosti mali dopad zhoršením jej ziskovosti,
a tým ohrozením stability verejnej lekárne do budúcnosti.
Related subjects:
Pharmacy,
Pharmacy, other

© 2015 I. Malovecká, K. Papargyris, D. Mináriková, V. Foltán, A. Jankovská, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 62 (2015): Issue 1 (June 2015)Next article